Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01068678

Public ClinicalTrials.gov record NCT01068678. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: EASY AM)

Study identification

NCT ID
NCT01068678
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
460 participants

Conditions and interventions

Interventions

  • insulin degludec Drug
  • insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2010
Primary completion
Oct 31, 2010
Completion
Oct 31, 2010
Last update posted
Mar 5, 2017

2010

United States locations

U.S. sites
57
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
Novo Nordisk Investigational Site Northridge California 91325
Novo Nordisk Investigational Site Palm Springs California 92262
Novo Nordisk Investigational Site Paramount California 90723
Novo Nordisk Investigational Site Santa Ana California 92704
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Melbourne Florida 32901
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Columbus Georgia 31909
Novo Nordisk Investigational Site Perry Georgia 31069
Novo Nordisk Investigational Site Olympia Fields Illinois 60461
Novo Nordisk Investigational Site Avon Indiana 46123
Novo Nordisk Investigational Site Fishers Indiana 46038-1862
Novo Nordisk Investigational Site Franklin Indiana 46131-9121
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Interlochen Michigan 49643
Novo Nordisk Investigational Site Jackson Mississippi 39216
Novo Nordisk Investigational Site Chesterfield Missouri 63017
Novo Nordisk Investigational Site City of Saint Peters Missouri 63376
Novo Nordisk Investigational Site Billings Montana 59101
Novo Nordisk Investigational Site Lincoln Nebraska 68521
Novo Nordisk Investigational Site Hamilton New Jersey 08619
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Durham North Carolina 27710
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103
Novo Nordisk Investigational Site Canton Ohio 44718
Novo Nordisk Investigational Site Cleveland Ohio 44115
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Pottstown Pennsylvania 19464
Novo Nordisk Investigational Site Upper St.Clair Pennsylvania 15241
Novo Nordisk Investigational Site Charleston South Carolina 29455
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Simpsonville South Carolina 29681
Novo Nordisk Investigational Site Nashville Tennessee 37203
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Arlington Texas 76014-2010
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Fort Worth Texas 76113
Novo Nordisk Investigational Site Houston Texas 77074
Novo Nordisk Investigational Site Houston Texas 77095
Novo Nordisk Investigational Site Irving Texas 75061-2210
Novo Nordisk Investigational Site Plano Texas 75024
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site Fredericksburg Virginia 22408-2674
Novo Nordisk Investigational Site Richmond Virginia 23225-4017
Novo Nordisk Investigational Site Virginia Beach Virginia 23462
Novo Nordisk Investigational Site Menomonee Falls Wisconsin 53051-4049

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01068678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2017 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01068678 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →